| 產品描述： | Udenafil (DA8159) is a potent, selective and orally active phosphodiesterase type 5 (PDE5) inhibitor. Udenafil also inhibits cGMP hydrolysis and can be used for erectile dysfunction research |
| 靶點： |
Phosphodiesterase (PDE);PDE |
| 參考文獻： |
1. Paick, J.S., et al., The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. J Sex Med, 2008. 5(4): p. 946-53. 2. Zhao, C., et al., Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int, 2011. 107(12): p. 1943-7. |
| 溶解性： |
DMSO : ≥ 33 mg/mL (63.87 mM) |
| 保存條件： |
2-8℃ |
| 配置溶液濃度參考： |
|
1mg |
5mg |
10mg |
| 1 mM |
1.936 ml |
9.678 ml |
19.355 ml |
| 5 mM |
0.387 ml |
1.936 ml |
3.871 ml |
| 10 mM |
0.194 ml |
0.968 ml |
1.936 ml |
| 50 mM |
0.039 ml |
0.194 ml |
0.387 ml |
|
| 注意： |
部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京